Results
|
|
11441.
|
|
|
|
11442.
|
|
|
|
11443.
|
Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost? [electronic resource] by
- Sibiude, Jeanne
- Warszawski, Josiane
- Tubiana, Roland
- Dollfus, Catherine
- Faye, Albert
- Rouzioux, Christine
- Teglas, Jean-Paul
- Ekoukou, Dieudonné
- Blanche, Stéphane
- Mandelbrot, Laurent
Producer: 20130129
In:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America vol. 54
Availability: No items available.
|
|
|
11444.
|
Compartment-specific gene regulation of the CAR inducer efavirenz in vivo. [electronic resource] by
- Meyer zu Schwabedissen, H E
- Oswald, S
- Bresser, C
- Nassif, A
- Modess, C
- Desta, Z
- Ogburn, E T
- Marinova, M
- Lütjohann, D
- Spielhagen, C
- Nauck, M
- Kroemer, H K
- Siegmund, W
Producer: 20120904
In:
Clinical pharmacology and therapeutics vol. 92
Availability: No items available.
|
|
|
11445.
|
|
|
|
11446.
|
|
|
|
11447.
|
|
|
|
11448.
|
Nevirapine-associated hepatotoxicity was not predicted by CD4 count ≥250 cells/μL among women in Zambia, Thailand and Kenya. [electronic resource] by
- Peters, P J
- Stringer, J
- McConnell, M S
- Kiarie, J
- Ratanasuwan, W
- Intalapaporn, P
- Potter, D
- Mutsotso, W
- Zulu, I
- Borkowf, C B
- Bolu, O
- Brooks, J T
- Weidle, P J
Producer: 20110224
In:
HIV medicine vol. 11
Availability: No items available.
|
|
|
11449.
|
|
|
|
11450.
|
SAMHD1 specifically affects the antiviral potency of thymidine analog HIV reverse transcriptase inhibitors. [electronic resource] by
- Ballana, Ester
- Badia, Roger
- Terradas, Gerard
- Torres-Torronteras, Javier
- Ruiz, Alba
- Pauls, Eduardo
- Riveira-Muñoz, Eva
- Clotet, Bonaventura
- Martí, Ramon
- Esté, José A
Producer: 20150914
In:
Antimicrobial agents and chemotherapy vol. 58
Availability: No items available.
|
|
|
11451.
|
|
|
|
11452.
|
Body composition and metabolic outcomes after 96 weeks of treatment with ritonavir-boosted lopinavir plus either nucleoside or nucleotide reverse transcriptase inhibitors or raltegravir in patients with HIV with virological failure of a standard first-line antiretroviral therapy regimen: a substudy of the randomised, open-label, non-inferiority SECOND-LINE study. [electronic resource] by
- Boyd, Mark A
- Amin, Janaki
- Mallon, Patrick W G
- Kumarasamy, Nagalingeswaran
- Lombaard, Johan
- Wood, Robin
- Chetchotisakd, Ploenchan
- Phanuphak, Praphan
- Mohapi, Lerato
- Azwa, Iskandar
- Belloso, Waldo H
- Molina, Jean-Michel
- Hoy, Jennifer
- Moore, Cecilia L
- Emery, Sean
- Cooper, David A
Producer: 20170727
In:
The lancet. HIV vol. 4
Availability: No items available.
|
|
|
11453.
|
|
|
|
11454.
|
|
|
|
11455.
|
|
|
|
11456.
|
|
|
|
11457.
|
|
|
|
11458.
|
|
|
|
11459.
|
|
|
|
11460.
|
|